Rated 2.8 / 5 (How Ratings Work)
Possible to probable range of efficacy of cannabis for treatment of addiction to nicotine.
Based on 17 Studies from 1994 - 2017
Study Name, Description & Year
Rating
The Endocannabinoid System As A Target For Addiction Treatment: Trials And Tribulations
Review — 2017
The Endocannabinoid System As A Target For Addiction Treatment: Trials And Tribulations
Review — 2017
Attenuation Of Cue-induced Reinstatement Of Nicotine Seeking By URB597 Through Cannabinoid CB1 Receptor In Rats
Animal study (rats) — 2016
Inhibition Of Monoacylglycerol Lipase (MAGL) Enhances Cue-induced Reinstatement Of Nicotine-seeking Behavior In Mice
Animal study (mice) — 2016
CB1 Cannabinoid Receptors Mediate Cognitive Deficits And Structural Plasticity Changes During Nicotine Withdrawal
Animal study (mice) — 2016
The Dark Side Of Emotion: The Addiction Perspective
Review — 2015
Neuroscience Of Nicotine For Addiction Medicine: Novel Targets For Smoking Cessation Medications
Review/Meta-Analysis — 2015
The Volitional Nature Of Nicotine Exposure Alters Anandamide And Oleoylethanolamide Levels In The Ventral Tegmental Area
Animal study (Wistar rats) — 2013
Cannabidiol Reduces Cigarette Consumption In Tobacco Smokers: Preliminary Findings
A randomised double blind placebo controlled study conducted on 24 smokers who wished to stop smoking. — 2013
Inhibition Of Fatty Acid Amide Hydrolase Reduces Reinstatement Of Nicotine Seeking But Not Break Point For Nicotine Self-administration--comparison With CB(1) Receptor Blockade
Animal study (rats) — 2009
Blocking Cannabinoid CB1 Receptors For The Treatment Of Nicotine Dependence: Insights From Pre-clinical And Clinical Studies
Animal study (rats) — 2008
The Cannabinoid Antagonist AM251 Attenuates Nicotine Self-administration And Nicotine-seeking Behaviour In Rats
Animal study (rats) — 2008
Neural Basis Of Delta-9-tetrahydrocannabinol And Cannabidiol: Effects During Response Inhibition
A double-blind, pseudo-randomized, placebo-controlled trial conducted on 15 healthy human volunteers. — 2008
CB1 Receptor Antagonists For The Treatment Of Nicotine Addiction.
Animal study (mice) — 2005
SR141716, A Central Cannabinoid (CB(1)) Receptor Antagonist, Blocks The Motivational And Dopamine-releasing Effects Of Nicotine In Rats
Animal study (rats) — 2002
Inhalation Of Vapor From Black Pepper Extract Reduces Smoking Withdrawal Symptoms
Placebo-controlled trial conducted on 48 cigarette smokers. — 1994